Presepsin level in children infected with community-acquired pneumonia
Keywords:
presepsin level, children infected, community-acquired pneumoniaAbstract
Objective: To investigate the expression of Presepsin (P-SEP) in children infected with Community-acquired pneumonia and its correlation with total white blood cell count (WBC), gender and age. The current study included sixty (60) patient suffering from acquired community pneumonia aged range between one year to larger than 6 years, gander (30) female and (30) male Children in Al Zahara Teaching Hospitals in Najaf Provenance , during November 2020 – March 2021. The (30) control Child without suffering any of symptoms or criteria of acquired community pneumonia our results show significant elevation (p<0.05) in Total Leukocytes count and presepsin in pneumonia patient group in comparison with control group and non-significant (p>0.05) different in presepsin level between female and male pneumonia child patients. The results also indicate significant elevation (p <0.05) in serum presepsin level of pneumonia child patient among the age (1-3 y) when compare with among the ages (4-6 y) and (>6y) of pneumonia child patient .And there is no significant (p>0.05) different in presepsin between the ages (4-6y) when compare with ages (>6y).
Downloads
References
Hema Latha B., Lakshmi Bhavani K., Akhil Kumar K.* Rajeshu D., B.A.Vishwanath, Ritty Sara Cherion. A prospective study on prescribing pattern of antibiotics for treating pneumonia in pediatrics in a tertiary care hospital, Bangalore: Volume 6, Issue 15, 1227-1260.( 2017)
World Health Organization. Pneumonia. Fact sheet No. 331. Geneva, Switzerland: World Health Organization; 2015 [accessed 2016 Oct 7]. Availablefrom: http://www.who.int/mediacentre/factsheets/fs331/en/#. V4HXptOHwK8.email
Zar HJ, Madhi SA, Aston SJ, Gordon SB. Pneumonia in low and middle income countries: progress and challenges. Thorax 2013;68:1052–1056.
Ali Imarah, A., Subhi Mohammed, M., Ahmed Najm, R., Al Zeyadi, M., Khayoon, S. Q., & Alhamadani, I. (2022). Effect of the Concentration Levels of Growth Hormone and Insulin-like Growth Factor I on the Polymorphisms of the Il12p40 Gene in Lung Cancer Patients. Archives of Razi Institute, 77(1), 413-419.
Florin, T. A., Ambroggio, L., Shah, S. S., Ruddy, R. M., Nylen, E. S., & Balmert, L. (2021). Urinary Proadrenomedullin and Disease Severity in Children With Suspected Community-acquired Pneumonia. The Pediatric Infectious Disease Journal, 40(12), 1070-1075.
Uwaezuoke, S. N., & Ayuk, A. C. (2017). Prognostic scores and biomarkers for pediatric community-acquired pneumonia: how far have we come?. Pediatric Health, Medicine and Therapeutics, 8, 9.
Al-Shemery, M. K., & Al-Dujaili, A. N. (2019, August). Estimation of osteoprotgrin level in B thalassemia patient. In AIP Conference proceedings (Vol. 2144, No. 1, p. 040011). AIP Publishing LLC.
Marazzi, M. G., Randelli, F., Brioschi, M., Drago, L., Romanò, C. L., Banfi, G., ... & Galliera, E. (2018). Presepsin: a potential biomarker of PJI? A comparative analysis with known and new infection biomarkers. International Journal of Immunopathology and Pharmacology, 31, 0394632017749356.
Al-Shemery, M. K., & Al-Dujaili, A. N. (2019). Estimation of Procollagen Type III Peptide (PIIIP) Level in β Thalassemia Patients. SCOPUS IJPHRD CITATION SCORE, 10(7), 653.
Zou, Q., Wen, W., & Zhang, X. C. (2014). Presepsin as a novel sepsis biomarker. World journal of emergency medicine, 5(1), 16.
Arai, Y., Mizugishi, K., Nonomura, K., Naitoh, K., Takaori-Kondo, A., & Yamashita, K. (2015). Phagocytosis by human monocytes is required for the secretion of presepsin. Journal of Infection and Chemotherapy, 21(8), 564-569.
Al-Fatlawi, N. A. G., Al-Dujaili, A. N., & Kammona, T. H. N. (2020, December). Assessment FC gamma receptors (FCGR) IIb in thrombocytopenia patients in Holy-Najaf. In AIP Conference Proceedings (Vol. 2290, No. 1, p. 020015). AIP Publishing LLC.
Zhang, J., Hu, Z. D., Song, J., & Shao, J. (2015). Diagnostic value of presepsin for sepsis: a systematic review and meta-analysis. Medicine, 94(47).
Jain, A., Awasthi, N., & Awasthi, S. (2018). Low platelet counts predict mortality in severe community acquired pneumonia in children under 5 years of age: a hospital based observational study. Clinical Epidemiology and Global Health, 6(4), 188-191.
Kartal O, Kartal AT. Value of neutrophil to lymphocyte and platelet to lymphocyte ratios in pneumonia. Bratisl Lek Listy. 2017;118(9):513-516. doi: 10.4149/BLL_2017_099. PMID: 29061056.
M. Don, F. Valent, M. Korppi, E. Falleti, A. De Candia, L. Fasoli, A. Tenore, M. Canciani, Efficacy of serum procalcitonin in evaluating severity of communityacquired pneumonia in childhood, Scand. J. Infect. Dis. 39 (2) (2007) 129–137.
F. Adler-Shohet, J.M. Lieberman, Bacterial pneumonia in children, Seminars in Pediatric Infectious Diseases, Elsevier, 1998, pp. 191–198.
R. Virkki, T. Juven, H. Rikalainen, E. Svedström, J. Mertsola, O. Ruuskanen, Differentiation of bacterial and viral pneumonia in children, Thorax 57 (5) (2002) 438–441.
Memar, M. Y., & Baghi, H. B. (2019). Presepsin: A promising biomarker for the detection of bacterial infections. Biomedicine & Pharmacotherapy, 111, 649-656.
Leli, C., Ferranti, M., Marrano, U., Al Dhahab, Z. S., Bozza, S., Cenci, E., & Mencacci, A. (2016). Diagnostic accuracy of presepsin (sCD14-ST) and procalcitonin for prediction of bacteraemia and bacterial DNAaemia in patients with suspected sepsis. Journal of medical microbiology, 65(8), 713-719.
Memar, M. Y., Varshochi, M., Shokouhi, B., Asgharzadeh, M., & Kafil, H. S. (2017). Procalcitonin: the marker of pediatric bacterial infection. Biomedicine & Pharmacotherapy, 96, 936-943.
Iskandar, A., Arthamin, M. Z., Indriana, K., Anshory, M., Hur, M., Di Somma, S., & GREAT Network. (2019). Comparison between presepsin and procalcitonin in early diagnosis of neonatal sepsis. The Journal of Maternal-Fetal & Neonatal Medicine, 32(23), 3903-3908.
Yokose, T., Takeuchi, M., Obara, H., Shinoda, M., Kawakubo, H., Kitago, M., ... & Kitagawa, Y. (2021). Diagnostic Utility of Presepsin in Infections After Liver Transplantation: A Preliminary Study. Annals of Transplantation, 26, e933774-1.
Ham, J. Y., & Song, K. E. (2019). A prospective study of presepsin as an indicator of the severity of community-acquired pneumonia in emergency departments: comparison with Pneumonia Severity Index and CURB-65 Scores. Laboratory medicine, 50(4), 364-369.
Hayashi, M., Yaguchi, Y., Okamura, K., Goto, E., Onodera, Y., Sugiura, A., ... & Suzuki, T. (2017). A case of extensive burn without sepsis showing high level of plasma presepsin (sCD14-ST). Burns Open, 1(1), 33-36.
Arai, Y., Mizugishi, K., Nonomura, K., Naitoh, K., Takaori-Kondo, A., & Yamashita, K. (2015). Phagocytosis by human monocytes is required for the secretion of presepsin. Journal of Infection and Chemotherapy, 21(8), 564-569.
Qi, Z. J., Yu, H., Zhang, J., & Li, C. S. (2018). Presepsin as a novel diagnostic biomarker for differentiating active pulmonary tuberculosis from bacterial community acquired pneumonia. Clinica Chimica Acta, 478, 152-156.
Klouche, K., Cristol, J. P., Devin, J., Gilles, V., Kuster, N., Larcher, R., ... & Dupuy, A. M. (2016). Diagnostic and prognostic value of soluble CD14 subtype (Presepsin) for sepsis and community-acquired pneumonia in ICU patients. Annals of intensive care, 6(1), 1-11.
Munger, J. A. (2015). Determination of Soluble CD14 Molecular Weight Variants in Human Plasma.
Sato, S., & Ichihara, K. (2016). Multivariate Analyses on Clinical Utility and Sources of Variation of Serum Presepsin as a Diagnostic Marker for Sepsis. Rinsho byori. The Japanese Journal of Clinical Pathology, 64(1), 34-39.
Unay-Demirel, O., Ignak, S., Orug, T., & Yuksel, M. (2020). Presepsin Levels in Experimental Sepsis and Massive Bowel Resection Models in Rats. in vivo, 34(1), 155-161.
Ciesielska, A., Matyjek, M., & Kwiatkowska, K. (2021). TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling. Cellular and molecular life sciences, 78(4), 1233-1261.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
